nodes were noted along the left internal jugular vein ( Figure 1B) . The blood test data were within the normal ranges. Under the suspicion of a pleomorphic adenoma, parotidectomy was performed on September 8, 2010. The tumor measured 5.0 Â 4.0 Â 1.2 cm 3 in size. Microscopically, most germinal centers in the lymph nodes were hyperplastic and areas of vascular proliferation could be seen in the interfollicular regions ( Figure 1C ). Foci showing lamination of the mantle cell layers with an "onion-skin" appearance were present ( Figure 1D ). These findings were suggestive of CD. Additional HHV-8 immunochemical staining of the lymph nodes was negative. Left facial muscle weakness and paresthesia were noted postoperatively. Muscular strength recovered 6 months postoperatively. The patient was still alive 5 years later.
The pathogenesis of CD is still not clearly understood. An association with HHV-8 was previously reported. 1 Historically, CD is classified into three types: the hyalinevascular type, the plasma-cell variant, and a mixture of the two. The two distinctive clinical characteristics are the presence of unicentric lymph nodes and that of multicentric lymph nodes. Unicentric CD (UCD) usually occurs in females 2 and has localized manifestations with only a subset of the patients presenting systemic symptoms. Multicentric CD is frequently accompanied by systemic Bcell-related symptoms due to cytokine activation, and presents with fever, weight loss, night sweats, weakness, fatigue, and fluid retention. 3 UCD is usually of the hyalinevascular type and has a relatively benign course. In contrast, the plasma-cell variant and the mixed type are usually found in multicentric CD, and tend to be clinically aggressive. According to the systematic review performed by Talat and Schulte, 4 the 3-year disease-free survival rate for patients with unicentric hyaline-vascular disease was 92.5%, as compared with 45.7% for those with multicentric plasma cell disease. 4 Multicentric CD can be treated by cytotoxic chemotherapy with or without steroid agents. 5 Targeting viral replication (with therapeutics such as zidovudine or valganciclovir) was one of the treatment options for maintenance therapy.
In conclusion, CD is a rare disease affecting the head and neck region. The gold standard for treating UCD has been surgery with regular follow-up. The patient, presenting with hyaline-vascular type UCD at the parotid gland, was still alive 5 years after surgical treatment.
